‘InnoPharma, Inc is now a wholly owned subsidiary of Pfizer, Inc’


A balanced business model that consists of a successful generic business and a specialty pharmaceutical strategy to drive higher long-term growth.

Learn More

FeaturedProductsImage5Marketed Products

Product launches are driving growth for reinvestment into the company and confirming successful product selection with limited competition at launch.

Learn More